|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Variation in candida spp, distribution and antifungal resistance rates a- mong bloodstream infection isolates by patient age: report from the SENTRY antimicrobial surveillance program(2008 --2009) 显示文摘 | Pfaller MA Castanheira M Messer SA | 2010 | Diagn Microbiol Infect Dis2010，68，3： | 1 |
| 2 | Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiologyof recurrent cases显示文摘 | Richter SS Galask RP Messer SA | | 0，，： | 1 |
| 3 | In vitro survey of triazole cross-resistance among more than 700 clinical isolates of aspergillus species显示文摘 | Pfaller MA Messer SA Boyken L | 2008 | J Clin MicrobioJ2008，46，8： | 1 |
| 4 | A global evaluation of vori- conazole activity tested against recent clinical isolates of Candida spp 显示文摘 | Diekema DJ Messer SA Hollis RJ | 2009 | Diagn Microbiol Inject Dis2009，63，2： | 1 |
| 5 | National surveillance of nosocomial blood stream infection due to Candida albicans:frequency of occurrence and antifun-gal susceptibility in the SCOPE Program显示文摘 | Pfaller MA Jones RN Messer SA | 1998 | Diagn Microbiol Infect Dis1998，31，1： | 1 |
| 6 | Activity of MK991(L-743872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp显示文摘 | Marco F Pfaller MA Messer SA | 1998 | Diagn Microbiol Infect Dis1998，32，1： | 1 |
| 7 | Activity of contemporary an- tifungal agents, including the novel echinocandin anidulafungin, tested against candida Spp, cryptococcus Spp and aspergillus Spp 显示文摘 | Messer SA Moet GJ Kirby JT | 2009 | J Clin Microbiol2009，47，6： | 1 |
| 8 | Activities of fluconazole and voriconazole against 1 586 recent clinical isolates of Candida species determined by Broth microdilution, disk diffusion, and Etest methods : report from the ARTEMIS Global Antifungal Susceptibility Program, 2001显示文摘 | Pfaller MA Diekema DJ Messer SA | 2003 | J Clin Microbial2003，41，4： | 1 |
| 9 | In vitro susceptibility testing of Filamentous fungi:comparison of Etest and reference microdilution methods for determining itroconazole MICs显示文摘 | Pfaller MA Messer SA Mills K | 2000 | J Clin Micro2000，38，9： | 1 |
| 10 | National surveillance of nosocomial blood stream infection due to Candida albicans:frequency of occurrence and antifungal susceptibility in the SCOPE Program显示文摘 | Pfaller MA Jones RN Messer SA | 1998 | Diagn Microbiol Infect Dis1998，31，1： | 1 |
| 11 | Trends in species distri-bution and susceptibility to fluconazole among blood stream iso-lates of Candida species in the United States显示文摘 | Pfaller MA Messer SA Hollis RJ | 1999 | Diagn MicrobiolInfect Dis1999，33，4： | 1 |
| 12 | In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp显示文摘 | Pfaller MA Messer SA Hollis RJ | 2002 | Antimicrob Agents Chemother2002，46，6： | 1 |
| 13 | Comparison of results of fluconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance with candidemia显示文摘 | Hazen KC Messer SA | 2004 | J Clin Microbiol2004，42，： | 1 |
| 14 | Characterization of heteroresistance to fluconazole amog clinical isolates of Cryptococcus ne of or mans显示文摘 | Yamazumi T Pfaller MA Messer SA | 2003 | J Clin Microbiol2003，41，1： | 1 |
| 15 | Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001 显示文摘 | Pfaller MA Diekema DJ Messer SA | 2003 | J Clin Microbial2003，41，4： | 1 |
| 16 | Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010to 2011:application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance显示文摘 | Pfaller MA Messer SA Woosley LN | 2013 | J Clin Microbiol2013，51，8： | 1 |
| 17 | Multicenter comparison of the sensititre yeastOne colorimetric antifungal panel with the NCCLS M27-A2reference method for testing new antifungal agents against clinical isolates of Candida spp显示文摘 | Espinel-Ingroff A Pfaller M Messer SA | 2004 | J Clin Microbiol2004，42，2： | 1 |
| 18 | A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp显示文摘 | Diekema DJ Messer SA Hollis RJ | 2009 | Diagn Microbiol Infect Dis2009，63，2： | 1 |
| 19 | Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases 显示文摘 | Richter SS Galask RP Messer SA | 2005 | J Clin Microbi- ol2005，43，5： | 1 |
| 20 | National surveillance of nosocomial blood stream infection due to Candida albicans; frequency of occurrence and antifungal susceptibility in the SCOPE program显示文摘 | Jones RN Messer SA | 1998 | Diagn Microbiol Infect Dis1998，31，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员